113 related articles for article (PubMed ID: 12943557)
1. Phenelzine treatment increases transcription factor AP-2 levels in rat brain.
Damberg M; Berggård C; Oreland L
BMC Pharmacol; 2003 Aug; 3():10. PubMed ID: 12943557
[TBL] [Abstract][Full Text] [Related]
2. Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.
Berggard C; Damberg M; Oreland L
BMC Pharmacol; 2005 Jan; 5():1. PubMed ID: 15663788
[TBL] [Abstract][Full Text] [Related]
3. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2.
Damberg M; Ekblom J; Oreland L
Life Sci; 2000 Dec; 68(6):669-78. PubMed ID: 11205881
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
5. Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain.
Berggård C; Damberg M; Oreland L
Eur Neuropsychopharmacol; 2003 Jan; 13(1):11-7. PubMed ID: 12480117
[TBL] [Abstract][Full Text] [Related]
6. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
Paslawski TM; Sloley BD; Baker GB
Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
8. Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain.
Damberg M; Eller M; Tõnissaar M; Oreland L; Harro J
Neurosci Lett; 2001 Nov; 313(1-2):102-4. PubMed ID: 11684350
[TBL] [Abstract][Full Text] [Related]
9. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
MacKenzie EM; Grant SL; Baker GB; Wood PL
Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
Heydendael W; Jacobson L
Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP-2 and monoaminergic functions in the central nervous system.
Damberg M
J Neural Transm (Vienna); 2005 Oct; 112(10):1281-96. PubMed ID: 15959839
[TBL] [Abstract][Full Text] [Related]
13. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
McKenna KF; McManus DJ; Baker GB; Coutts RT
J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
[TBL] [Abstract][Full Text] [Related]
15. Redistribution of transcription factor AP-2alpha in differentiating cultured human epidermal cells.
Mazina OM; Phillips MA; Williams T; Vines CA; Cherr GN; Rice RH
J Invest Dermatol; 2001 Oct; 117(4):864-70. PubMed ID: 11676824
[TBL] [Abstract][Full Text] [Related]
16. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
18. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
Blier P; De Montigny C; Azzaro AJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes.
Takahashi H; Oyama N; Itoh Y; Ishida-Yamamoto A; Kaneko F; Iizuka H
Biochem Biophys Res Commun; 2000 Nov; 278(3):719-23. PubMed ID: 11095974
[TBL] [Abstract][Full Text] [Related]
20. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB
Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
